Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

EU announces investment in new treatments for Parkinson’s

Parkinson’s will be one of the main health areas to benefit from funding under the European Investment Bank’s (EIB) latest investment round.

The EIB – the EU’s long-term lending institution – has approved €10 billion of loans for a variety of strategic projects around the world.

These include medical research into Parkinson’s and epilepsy, as well as a host of infrastructure projects and investment in corporate research in the energy, automobile, and textile sectors.

Details of the investment in Parkinson’s have yet to be announced, but previously the EIB has provided funds for the development of new treatments by the Portuguese pharmaceutical company Bial.

In 2010-13 the EIB committed €50 million in loans to Bial’s research and development activities on drugs for epilepsy, cardiovascular affections and Parkinson’s disease.

Go Back

Share this story

Comments


Related articles


A Cell's Life lead

Resources & Tools

‘A Cell’s Life’: the comic strip demystifying Parkinson’s research

Web comic book series explains Parkinson's stem cell treatments

READ MORE
Mike Bell World Parkinsons Day lead

Perspectives

Poem for World Parkinson’s Day: “Parkinson’s can be a state of mind, rather than an illness”

Daily Parkinson’s poet pens new piece for World Parkinson’s Day

READ MORE
Parkinson's

Interviews

“People are capable of so much more than they think”

We talk to Dr Modugno about the centre he directs in Italy

READ MORE